Effects of anti-sclerostin antibody and running on bone remodeling and strength

Sclerostin antibody (Scl-Ab) represents a promising therapeutic approach to treat patients with osteoporosis. Purpose: The aim of this study was to investigate the effects of Scl-Ab, running and a combination of both on bone formation. Methods: Sixty female Wistar rats, aged 8 months were randomly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Toumi, H., Benaitreau, D., Pallu, S., Mazor, M., Hambli, R., Ominsky, M., Lespessailles, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365189/
https://www.ncbi.nlm.nih.gov/pubmed/28377954
http://dx.doi.org/10.1016/j.bonr.2015.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365189/
https://www.ncbi.nlm.nih.gov/pubmed/28377954
http://dx.doi.org/10.1016/j.bonr.2015.03.002

Ejemplares similares